Homozigot ailevi hiperkolesterolemi: klinisyenlerin tanıyı ve klinik yönetimi geliştirmelerine yönelik yeni anlayışlar ve rehberlik. Avrupa Ateroskleroz Derneği’nin Ailevi Hiperkolesterolemi Üzerine Uzlaşı Paneli yazılı görüşü
Marina Cuchel(University of Pennsylvania), M. John Chapman(Inserm), Jan Albert Kuivenhoven(University Medical Center Groningen), Albert Wiegman(Amsterdam University Medical Centers), Olov Wiklund(Translational Therapeutics (United States)), Klaus G. Parhofer(LMU Klinikum), Elisabeth Steinhagen‐Thiessen(Charité - Universitätsmedizin Berlin), Robert A. Hegele(Western University), Frederick J. Raal(University of the Witwatersrand), Jan Borén(Göteborgs Stads), Raúl D. Santos(Universidade de São Paulo), Cathérine Boileau(Hôpital Necker-Enfants Malades), Éric Bruckert(Centre de Recherche Médecine, Sciences, Santé, Santé Mentale, Société), L. Masana(Universitat Rovira i Virgili), Marja‐Riitta Taskinen(Hospital District of Helsinki and Uusimaa), Steve E. Humphries(University College London), Päivi Pajukanta(University of California, Los Angeles), Joep C. Defesche(Academic Medical Center), Maurizio Averna(Instituto di Biofisica), Gerald F. Watts(Royal Perth Hospital), Børge G. Nordestgaard(Gentofte Hospital), Erik S.G. Stroes(Amsterdam University Medical Centers), Petri T. Kovanen(Wihuri Research Institute), Alberico L. Catapano(University of Milan), Olivier Descamps(Centre Hospitalier Universitaire de Tivoli), G. Kees Hovingh(Academic Medical Center), Anne Tybjærg‐Hansen(University of Copenhagen), Kausik K. Ray(Imperial College London), Anton F. H. Stalenhoef(Translational Therapeutics (United States)), Henry N. Ginsberg(Columbia University)
Unknown
March 1, 2015
Cited by 465
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k
2014 ESC Guidelines on the diagnosis and treatment of aortic diseases
|European Heart Journal|2014|4.4k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k